Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856895 · ClinicalTrials.gov registry record
Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients
A clinical trial of Transplant;Failure,Kidney, sponsored by Northwestern University.
- Active
- Registry status
- 1,200
- Enrollment target
- 1
- Study location
NCT00856895: Active study of Transplant;Failure,Kidney, sponsored by Northwestern University.
NCT00856895 is a study of Transplant;Failure,Kidney that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 1,200 participants, above the 74-participant average among 8 other Transplant;Failure,Kidney trials with a reported enrollment target (1522% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00856895, a study of Transplant;Failure,Kidney, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of study is to measure the quality of life (QOL) of patients pre and post kidney transplant by asking them to fill out a survey. Patients will be asked to fill out the survey before transplant, 3 months post-transplant, and 1 year post-transplant to see how the transplant relates to any progression in quality of life. QOL will be assessed to correlate the quality of life and aspects of renal function prospectively at pre and post-transplant across all ethnicities and variances of donor types at three time points. First, there will be a prospective assessment of QOL in the Hispanic and Non-Hispanic kidney recipients before and after transplant at NMH and Colombiana de Transplantes. Second, there will be an assessment of the Hispanic kidney patients that have been transplanted over the last 10 years at NMH and Colombiana de Transplantes, in a cross-sectional fashion. Third, there will be a comparison and determination of the differences in QOL in the Hispanic population before and after the Hispanic Transplant program was initiated in November 2006. Lastly, there will be an assessment of the social impact of the services that NMH's Hispanic Transplant Program provides to patients. The questionnaires completed by the subjects at NMH will be the same questionnaires completed by the subjects in Colombia. The data obtained from Colombiana de Transplantes will be de-identified data and provided to us via a password protected excel file delivered to the principal investigator electronically.
Primary Outcome
To evaluate long term QOL outcomes in Hispanic and Non-Hispanic kidney transplant recipients in a prospective longitudinal study using QOL questionnaires before and after transplant.
Conditions Studied
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2007-10 |
| Est. Completion | 2026-03 |
What the registry record for NCT00856895 still lists
NCT00856895 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 74-participant average among 8 other Transplant;Failure,Kidney trials with a reported enrollment target (1522% higher).
The record links to 1 condition, with Transplant;Failure,Kidney appearing as the primary indexed condition, and to 0 interventions.
NCT00856895 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00856895 about?
NCT00856895 is a clinical study titled "Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients". The purpose of study is to measure the quality of life (QOL) of patients pre and post kidney transplant by asking them to fill out a survey. Patients will be asked to fill out the survey before transplant, 3 months post-transplant, and 1 year post-transplant to see how the transplant relates to any ...
What is the current status of trial NCT00856895?
This trial is currently active not recruiting. The enrollment target is 1,200 participants. The study started on 2007-10. Estimated completion is 2026-03.
What conditions does trial NCT00856895 study?
This clinical trial studies the following conditions: Transplant;Failure,Kidney.
Who is sponsoring clinical trial NCT00856895?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00856895 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant;Failure,Kidney
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00856895's enrollment target sits among peer trials
1,200 1st of 8 higher than 8 of 8 other Transplant;Failure,Kidney trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Transplant;Failure,Kidney trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Abdominal Wall Transplant
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
RECRUITING · NA
-
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
RECRUITING · Phase 4
-
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia